Literature DB >> 26626773

The Use of Structural Distal Femoral Allograft for Acetabular Reconstruction of Paprosky Type IIIA Defects at a Mean 21 Years of Follow-Up.

Nicholas M Brown1, Joe Morrison2, Scott M Sporer3, Wayne G Paprosky3.   

Abstract

BACKGROUND: Revision total hip arthroplasty in patients with a nonsupportive superior acetabulum often requires secondary augmentation beyond a hemispherical cup to achieve reliable fixation. Treatment options include using a higher hip center, jumbo cup, custom triflange implant, cages, or filling the superior defect with a bilobed implant, structural allograft, or metal augments. We previously reported a cohort of 31 patients treated with porous-coated hemispherical cups and distal femoral allograft for Paprosky type IIIA acetabular defects.
METHODS: The original cohort of 31 hips was retrospectively reviewed. Fourteen patients died with <15 years of follow-up, and 2 were lost to follow-up. This left 15 patients for evaluation including 5 males and 10 females, with an average age of 61 years (range: 37-74 years) at the time of surgery. Acetabular revision was performed with the use of a porous-coated hemispherical cup along with structural distal femoral allograft, cut to resemble the number 7, and secured with 6.5-mm cancellous screws with washers.
RESULTS: Overall, 7 hips failed, resulting in a Kaplan-Meier survivorship of 72% at 25 years of follow-up. In surviving patients, radiographs demonstrated components to be well fixed, and average Merle d'Aubigné score increased from 5 to 10 points. There were a subset of patients that failed early (median: 6.2 years), but the remaining patients demonstrated excellent clinical and radiographic results.
CONCLUSIONS: The use of distal femoral allograft can be considered in young patients with type IIIA acetabular defects that could benefit from restoration of bone stock.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Paprosky type IIIA; acetabular defect; distal femoral allograft; revision total hip arthroplasty; structural allograft

Mesh:

Year:  2015        PMID: 26626773     DOI: 10.1016/j.arth.2015.10.020

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  7 in total

1.  [Treatment of acetabular defects with the trabecular metal revision system].

Authors:  G I Wassilew; V Janz; C Perka; M Müller
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

Review 2.  Femoral revision with primary cementless stems: a systematic review of the literature.

Authors:  Luca Cavagnaro; Matteo Formica; Marco Basso; Andrea Zanirato; Stefano Divano; Lamberto Felli
Journal:  Musculoskelet Surg       Date:  2017-07-01

3.  Reconstruction of Paprosky type IIIB acetabular bone defects using a cup-on-cup technique: A surgical technique and case series.

Authors:  Yin-Qiao Du; Yu-Ping Liu; Jing-Yang Sun; Ming Ni; Yong-Gang Zhou
Journal:  World J Clin Cases       Date:  2020-04-06       Impact factor: 1.337

4.  Modular revision strategy with bispherical augments in severe acetabular deficiency reconstruction.

Authors:  Guo-Yuan Li; Xiao-Qi Zhang; Min Chen; Zheng-Liang Luo; Xiao-Feng Ji; Xi-Fu Shang
Journal:  Int Orthop       Date:  2021-08-27       Impact factor: 3.075

5.  Structural and Morselized Allografting Combined with a Cementless Cup for Acetabular Defects in Revision Total Hip Arthroplasty: A 4- to 14-Year Follow-Up.

Authors:  Hou-Tsung Chen; Cheng-Ta Wu; Tsan-Wen Huang; Hsin-Nung Shih; Jun-Wen Wang; Mel S Lee
Journal:  Biomed Res Int       Date:  2018-02-04       Impact factor: 3.411

6.  The direct anterior approach for acetabular augmentation in primary total hip arthroplasty.

Authors:  Erin Honcharuk; Stephen Kayiaros; Lee E Rubin
Journal:  Arthroplast Today       Date:  2017-05-12

Review 7.  Clinical and radiological outcomes of jumbo cup in revision total hip arthroplasty: A systematic review.

Authors:  Qiuyuan Wang; Qi Wang; Pei Liu; Juncheng Ge; Qidong Zhang; Wanshou Guo; Weiguo Wang
Journal:  Front Surg       Date:  2022-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.